1348P Long-term survival and health-related quality of life with nivolumab for previously-treated advanced non-small cell lung cancer (NSCLC): A wide prospective French real-world study (EVIDENS)

EVIDENS is a prospective, observational and multicenter study of NSCLC patients treated with nivolumab after prior chemotherapy. Prior report showed consistent outcomes as compared with randomized clinical trials1. We report here long-term overall survival (OS) and health-related quality of life (HRQoL).